Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12611000909921Phase 2Not yet recruiting
Phase 2, randomised, double-blind trial of clonidine, fentanyl and bupivacaine in postoperative pain (3 arms), sponsored by Qazvin University of Medical Sciences. Primary endpoint: Time to first requirement of analgesic supplement. Planned start Aug 2011; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12611000909921.